FDA Import Refusal 799-4975019-3/11/1 — Takeda Pharmaceutical Company Limited
The FDA refused shipment 799-4975019-3/11/1 from Takeda Pharmaceutical Company Limited (Japan) on October 19, 2021. The refused product falls under Drugs and Biologics — ANTI-NEOPLASTIC N.E.C.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- October 19, 2021
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 62IDA99 ANTI-NEOPLASTIC N.E.C.
- Charges
- 118,75